Find the products and resources you are looking for!
Get in touch!
Our local employees are always happy to answer your questions. Highly trained and experienced teams in your country can provide quick, helpful, and comprehensive support.
Miltenyi Biotec distribution:
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
Cookie Settings
We use cookies in order to provide the best possible website experience for you. This includes cookies that are technically required to ensure a proper functioning of the website, as well as cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for displaying personalized content. You are free to choose the categories you would like to permit. Please note that depending on your settings, the full functionality of the website may no longer be available. Further information can be found in our Privacy Statement.
Mouse breast carcinoma cells were purified from a mouse 4T1 tumor using the Tumor Cell Isolation Kit, mouse, an LS Column, and a QuadroMACS™ Separator. The 4T1 tumor cells were GFP-labeled prior to tumor induction for subsequent detection. After tumor dissociation and sorting, the unseparated fraction and the negative fraction were analyzed by flow cytometry for GFP and lineage markers (CD45, Ter119, and CD31 combined in the APC channel) using the MACSQuant ® Analyzer. |
Before separation | Isolated mouse tumor cells |
Figure 1Mouse breast carcinoma cells were purified from a mouse 4T1 tumor using the Tumor Cell Isolation Kit, mouse, an LS Column, and a QuadroMACS™ Separator. The 4T1 tumor cells were GFP-labeled prior to tumor induction for subsequent detection. After tumor dissociation and sorting, the unseparated fraction and the negative fraction were analyzed by flow cytometry for GFP and lineage markers (CD45, Ter119, and CD31 combined in the APC channel) using the MACSQuant ® Analyzer. | Figure 1Mouse breast carcinoma cells were purified from a mouse 4T1 tumor using the Tumor Cell Isolation Kit, mouse, an LS Column, and a QuadroMACS™ Separator. The 4T1 tumor cells were GFP-labeled prior to tumor induction for subsequent detection. After tumor dissociation and sorting, the unseparated fraction and the negative fraction were analyzed by flow cytometry for GFP and lineage markers (CD45, Ter119, and CD31 combined in the APC channel) using the MACSQuant ® Analyzer. |
GFP-expressing mouse colon carcinoma cells (CT26.WT) were isolated from a heterogenous cell population and subsequently, the unseparated fraction and the mouse tumor cell fraction were cultured for three days in expansion medium (90% RPMI-1640, 10% FBS, 100 U/mL penicillin, and 100 U/mL streptomycin). After fixation, cells were stained using CD90.2 antibody (red) and cell nuclei were stained with DAPI (blue). The tumor cells were detected by their expression of GFP (green). |
Before separation | Isolated mouse tumor cells |
Figure 2GFP-expressing mouse colon carcinoma cells (CT26.WT) were isolated from a heterogenous cell population and subsequently, the unseparated fraction and the mouse tumor cell fraction were cultured for three days in expansion medium (90% RPMI-1640, 10% FBS, 100 U/mL penicillin, and 100 U/mL streptomycin). After fixation, cells were stained using CD90.2 antibody (red) and cell nuclei were stained with DAPI (blue). The tumor cells were detected by their expression of GFP (green). | Figure 2GFP-expressing mouse colon carcinoma cells (CT26.WT) were isolated from a heterogenous cell population and subsequently, the unseparated fraction and the mouse tumor cell fraction were cultured for three days in expansion medium (90% RPMI-1640, 10% FBS, 100 U/mL penicillin, and 100 U/mL streptomycin). After fixation, cells were stained using CD90.2 antibody (red) and cell nuclei were stained with DAPI (blue). The tumor cells were detected by their expression of GFP (green). |
Mouse breast carcinoma cells were purified from a mouse 4T1 tumor using the Tumor Cell Isolation Kit, mouse, an LS Column, and a QuadroMACS™ Separator. The 4T1 tumor cells were GFP-labeled prior to tumor induction for subsequent detection. After tumor dissociation and sorting, the unseparated fraction and the negative fraction were analyzed by flow cytometry for GFP and lineage markers (CD45, Ter119, and CD31 combined in the APC channel) using the MACSQuant ® Analyzer. |
Before separation | Isolated mouse tumor cells |
Figure 1Mouse breast carcinoma cells were purified from a mouse 4T1 tumor using the Tumor Cell Isolation Kit, mouse, an LS Column, and a QuadroMACS™ Separator. The 4T1 tumor cells were GFP-labeled prior to tumor induction for subsequent detection. After tumor dissociation and sorting, the unseparated fraction and the negative fraction were analyzed by flow cytometry for GFP and lineage markers (CD45, Ter119, and CD31 combined in the APC channel) using the MACSQuant ® Analyzer. | Figure 1Mouse breast carcinoma cells were purified from a mouse 4T1 tumor using the Tumor Cell Isolation Kit, mouse, an LS Column, and a QuadroMACS™ Separator. The 4T1 tumor cells were GFP-labeled prior to tumor induction for subsequent detection. After tumor dissociation and sorting, the unseparated fraction and the negative fraction were analyzed by flow cytometry for GFP and lineage markers (CD45, Ter119, and CD31 combined in the APC channel) using the MACSQuant ® Analyzer. |
GFP-expressing mouse colon carcinoma cells (CT26.WT) were isolated from a heterogenous cell population and subsequently, the unseparated fraction and the mouse tumor cell fraction were cultured for three days in expansion medium (90% RPMI-1640, 10% FBS, 100 U/mL penicillin, and 100 U/mL streptomycin). After fixation, cells were stained using CD90.2 antibody (red) and cell nuclei were stained with DAPI (blue). The tumor cells were detected by their expression of GFP (green). |
Before separation | Isolated mouse tumor cells |
Figure 2GFP-expressing mouse colon carcinoma cells (CT26.WT) were isolated from a heterogenous cell population and subsequently, the unseparated fraction and the mouse tumor cell fraction were cultured for three days in expansion medium (90% RPMI-1640, 10% FBS, 100 U/mL penicillin, and 100 U/mL streptomycin). After fixation, cells were stained using CD90.2 antibody (red) and cell nuclei were stained with DAPI (blue). The tumor cells were detected by their expression of GFP (green). | Figure 2GFP-expressing mouse colon carcinoma cells (CT26.WT) were isolated from a heterogenous cell population and subsequently, the unseparated fraction and the mouse tumor cell fraction were cultured for three days in expansion medium (90% RPMI-1640, 10% FBS, 100 U/mL penicillin, and 100 U/mL streptomycin). After fixation, cells were stained using CD90.2 antibody (red) and cell nuclei were stained with DAPI (blue). The tumor cells were detected by their expression of GFP (green). |
Copyright © 2021 Miltenyi Biotec and/or its affiliates. All rights reserved.